Joel White, Owner of Marketcap Consulting, joins another episode to discuss the evolving role of Clinical Research Organizations (CROs). He shares the characteristics of a great CRO, how technology and decentralization are shaping the industry, and the strategic balance between speed, quality, and cost in clinical trials. Whether you're a sponsor, CRO professional, or simply curious about the clinical trial landscape, this episode offers practical wisdom and forward-looking perspectives on drug development and innovation.

00:31 Joel White returns to explore CRO excellence and innovation

01:00 Joel’s background and journey into the CRO industry

01:55 Origins of Joel’s LinkedIn quarterly recaps and their impact

04:10 Defining CROs and their evolving role in clinical trials

05:48 What separates great CROs from average ones, such as customer service and repeat business

08:59 Technology’s role in CRO operations and vendor management

11:29 Balancing speed, quality, and cost in fast-paced trials

12:45 The importance of culture and leadership in CRO success

13:57 Common misconceptions sponsors have about CROs

16:45 Decentralization in clinical trials, including adoption trends and cost tradeoffs

19:05 Evaluating therapeutic area expertise when selecting a CRO

20:46 The future of CROs, consisting of innovation, partnerships, and the potential impact of AI